arrow
F

Francesca Fiorentino

ghent university hospital
H指数:28
被引数:3,055

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DEVELOPMENT AND VALIDATION OF A DEEP LEARNING TOOL FOR AUTOMATED READING OF FLUORESCENCE CONFOCAL MICROSCOPY IMAGES IN RADICAL PROSTATECTOMY

开发并验证用于在根治性前列腺切除术中对荧光共聚焦显微镜图像进行自动读取的深度学习工具

2026-05-010
PRE
COMPLETE PATHOLOGICAL RESPONSE OF THE PRIMARY TUMOUR AND IMPLICATIONS FOR CYTOREDUCTIVE TREATMENT IN DE NOVO METASTATIC PROSTATE CANCER: ANALYSIS FROM THE IP2-ATLANTA PHASE II RANDOMISED STUDY

原发肿瘤的完全病理缓解及其对去势抵抗性治疗的影响:IP2-ATLANTA II期随机研究的分析

2026-05-010
PRE
IP8-FLUORESCE: A Prospective Paired Cohort Study Evaluating the Diagnostic Accuracy of Fluorescence Confocal Microscopy for Real-time Assessment of Surgical Margins in Radical Prostatectomy

IP8-FLUORESCE:一项前瞻性配对队列研究,评估荧光共聚焦显微镜对根治性前列腺切除术术中实时评估手术切缘的诊断准确性。

2025-10-100
OAAI
Combination Cytoreductive Surgery, Radiotherapy, or Ablation for De Novo Metastatic Prostate Cancer: The IP2-ATLANTA Internal Pilot, Phase 2, Randomised Controlled Trial

联合细胞减灭术、放射治疗或消融术治疗原发性转移性前列腺癌:IP2-ATLANTA内部试点,II期,随机对照试验

2025-06-010
OAAI
Prostate Pathway Embedded Comparative Trial: Outcomes from the Pilot Phase of the Imperial Prostate 3—PROState Pathway Embedded Comparative Trial

前列腺通路嵌入式比较试验:帝国前列腺3—PRO前列腺通路嵌入式比较试验试点阶段的结果

2025-06-010
OAAI
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib

使用英夫利昔单抗或托法替尼的炎症性肠病患者对流感疫苗的抗体反应减弱

2023-11-062
OAAI
Prostagram magnetic resonance imaging in a screening population: Prostate Imaging-Reporting and Data System or Likert?

筛查人群中的前列腺素磁共振成像: 前列腺成像-报告和数据系统或Likert?

2023-10-160
OAAI
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study

炎症性肠病患者在三剂新型冠状病毒肺炎疫苗 (VIP) 后中和针对SARS-CoV-2 Omicron BA.4/5和野生型病毒的抗体反应: 一项前瞻性、多中心、队列研究

2023-10-013
OAAI
An Evaluation of Screening Pathways Using a Combination of Magnetic Resonance Imaging and Prostate-specific Antigen: Results from the IP1-PROSTAGRAM Study

结合使用磁共振成像和前列腺特异性抗原对筛查途径的评估: IP1-PROSTAGRAM研究的结果

2023-06-0110
OA
Perceived patient burden and acceptability of MRI in comparison to PSA and ultrasound: results from the IP1-PROSTAGRAM study

与PSA和超声相比,MRI的感知患者负担和可接受性: IP1-PROSTAGRAM研究的结果

2023-03-310
OAAI
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study

免疫抑制的炎症性肠病患者在第三次疫苗剂量 (VIP) 后新型冠状病毒肺炎疫苗诱导的抗体和T细胞反应: 一项多中心,前瞻性,病例对照研究

2022-11-0141
OAAI
Remote COVID-19 Assessment in Primary Care (RECAP) risk prediction tool: derivation and real-world validation studies

初级保健远程新型冠状病毒肺炎评估 (RECAP) 风险预测工具: 推导和现实世界验证研究

2022-09-013
OAAI
Direct mail from primary care and targeted recruitment strategies achieved a representative uptake of prostate cancer screening

来自初级保健的直邮和有针对性的招募策略实现了前列腺癌筛查的代表性吸收

2022-09-011
OA